PK
Pramit Kumar Ghosh
About Pramit Kumar Ghosh
Data last updated:
Pramit Kumar Ghosh is a Director at Celebrity Biopharma Limited (since 2024). The company operates in Pharma. Celebrity Biopharma Limited reported revenue of ₹65.65 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Celebrity Biopharma Limited U24230HP2005PLC028852 | Director | 28 Nov 2024 | 2005 | ₹65.65 Cr (FY 2024) | Active |
Board colleagues of Pramit Kumar Ghosh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhay Kumar | 08881348 | Celebrity Biopharma Limited | Director |
| Aditya Keshav Nir | 09262022 | Celebrity Biopharma Limited | Director |
| Amrendra Kumar Singh | 06762037 | Celebrity Biopharma Limited | Director |
| Niraj Kumar Nir | 02907592 | Celebrity Biopharma Limited | Managing Director |
| Prem Kumar Sharma | 06754194 | Celebrity Biopharma Limited | Director |
| Ravi Kant Sahay | Celebrity Biopharma Limited | Cfo | |
| Sakshi Thakur | 09616264 | Celebrity Biopharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pramit Kumar Ghosh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pramit Kumar Ghosh
Pramit Kumar Ghosh currently holds 1 directorship: Celebrity Biopharma Limited (Director, since 28 Nov 2024, revenue ₹65.65 Cr (FY 2024)).
Pramit Kumar Ghosh was first appointed on 28 Nov 2024 as Director at Celebrity Biopharma Limited.
The current boards of Pramit Kumar Ghosh's companies include Abhay Kumar (Celebrity Biopharma Limited), Aditya Keshav Nir (Celebrity Biopharma Limited), Amrendra Kumar Singh (Celebrity Biopharma Limited), Niraj Kumar Nir (Celebrity Biopharma Limited), Prem Kumar Sharma (Celebrity Biopharma Limited), Ravi Kant Sahay (Celebrity Biopharma Limited), among others.